Virtual Library
Start Your Search
Matthew Hellman
Author of
-
+
D02 - Optimal therapy for stage 4 NSCLC patient with low PD-L1 expression (1-49%) (ID D02)
- Event: TTLC 2020
- Type: General Session
- Track:
- Presentations: 1
-
+
Ipi plus Nivo (ID D02.02)
15:20 - 15:35 | Author(s): Matthew Hellman
- Abstract
Abstract not provided